Biopharma Trends 2025: 3 Things to Know Right Now
The global business climate is ever-evolving, and 2025 looks like it may be particularly challenging. Nowhere is that more evident than in the biopharma space, which is contending with multiple factors including a new administration in the US, new regulatory requirements in the EU, supply chain issues, and an uncertain economy. Despite these obstacles, however,…...
Read MoreTop Stories
Science, AI, and Human Ingenuity Converge to
Today, we're witnessing an unprecedented convergence of...
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
Leveraging Social Media to Transform Medical
This whitepaper explores the role of social media in...
Filter
EU MDR: Increasing Expectations for Clinical Evidence
While the global medical devices industry is closely watching how the European Union (EU) Medical...
Fireside Chat Part 1: How MedTech Leaders Are Called to Respond to EU MDR
A fireside chat on how MedTech leaders are called to respond to EU-MDR...
Awareness of International Publication Guidelines in Asia
This poster presents the results of an analysis of how familiar Asian authors are with...
US FDA (Food And Drug Administration) Social Medial Usage Guidelines: Compliance for Pharma Companies
This poster presents results of an analysis of trends in adherence of pharmaceutical companies to...